27,280 Shares of Prestige Consumer Healthcare Inc. $PBH Purchased by Milestone Asset Management LLC

Key Points

• Milestone Asset Management acquired 27,280 shares of Prestige Consumer Healthcare in the third quarter, worth approximately $1.25 million, while institutional investors collectively own 99.95% of the company.
• Prestige Consumer Healthcare reported quarterly EPS of $0.98, exceeding the $0.89 consensus estimate, while revenue rose 6.5% year over year to $265.71 million.
• PBH shares opened at $49.19, compared with a consensus analyst price target of $67.67. Analyst sentiment remains mixed, resulting in an overall “Hold” rating.

Milestone Asset Management LLC acquired a new stake in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 27,280 shares of the company's stock, valued at approximately $1,251,000. Milestone Asset Management LLC owned approximately 0.06% of Prestige Consumer Healthcare at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. BlackRock Inc. acquired a new position in shares of Prestige Consumer Healthcare during the 2nd quarter worth approximately $370,187,000. Dimensional Fund Advisors LP increased its holdings in shares of Prestige Consumer Healthcare by 3.6% in the first quarter. Dimensional Fund Advisors LP now owns 2,672,777 shares of the company's stock valued at $158,414,000 after purchasing an additional 91,710 shares during the last quarter. Rice Hall James & Associates LLC purchased a new position in Prestige Consumer Healthcare during the second quarter worth approximately $32,602,000. The Manufacturers Life Insurance Company purchased a new position in Prestige Consumer Healthcare during the second quarter worth approximately $31,135,000. Finally, Bank of America Corp DE purchased a new position in Prestige Consumer Healthcare during the second quarter worth approximately $26,277,000. Institutional investors and hedge funds own 99.95% of the company's stock.

Prestige Consumer Healthcare Stock Performance

NYSE:PBH opened at $49.19 on Friday. The company has a debt-to-equity ratio of 1.06, a current ratio of 3.23 and a quick ratio of 1.99. The firm has a market capitalization of $2.33 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 1.52 and a beta of 0.34. The company's 50-day moving average is $49.26 and its two-hundred day moving average is $50.38. Prestige Consumer Healthcare Inc. has a 1-year low of $42.62 and a 1-year high of $71.07.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $0.98 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.09. The business had revenue of $265.71 million during the quarter, compared to analysts' expectations of $253.02 million. Prestige Consumer Healthcare had a net margin of 15.57% and a return on equity of 11.39%. The business's revenue for the quarter was up 6.5% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.90 EPS. Prestige Consumer Healthcare has set its FY 2027 guidance at 4.550-4.650 EPS. Analysts forecast that Prestige Consumer Healthcare Inc. will post 4.56 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have issued reports on PBH shares. Weiss Ratings restated a "sell (d+)" rating on shares of Prestige Consumer Healthcare in a report on Tuesday, September 22nd. Zacks Research raised Prestige Consumer Healthcare from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, September 30th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $67.67.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc NYSE: PBH is a consumer healthcare company that develops, markets and distributes over-the-counter (OTC) products and household health-care brands. Its portfolio includes products for eye care, oral care, gastrointestinal health, pain relief, respiratory health, women's health, and other everyday health needs.

The company's brands include Dramamine, Bonine, BC, Goody's, Clear Eyes, TheraTears, Monistat, Summer's Eve, Vagisil, Luden's, Chloraseptic, Compound W, Fleet and Debrox.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.